Latest United States News

Nelson Resources has completed a comprehensive soil sampling program at its Cinnamon Property in Nevada, affirming a high-grade copper-gold discovery at Sheba and prioritising the near-surface tungsten potential at Ophir.

Diablo Resources has secured an 80% stake in the historic Horn Silver Project in Utah, unlocking a portfolio of high-grade silver, gold, copper, and antimony targets. The acquisition complements its nearby Star Range assets and aligns with US critical minerals priorities.

BlueScope Steel posted a remarkable 857% jump in reported NPAT to $802 million for FY2026, underpinned by strong US spreads, cost discipline, and growth in value-added steel products. The company declared record dividends and advanced key decarbonisation projects, signaling a confident transition from investment to shareholder returns.

Laramide Resources has raised $5 million through a private placement of 8.35 million shares at $0.60 each to a strategic investor, bolstering working capital for its uranium projects in the US and Australia.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

Li-FT Power Ltd. has completed a C$23 million bought deal public offering, including full exercise of the over-allotment option, to support care and maintenance costs for the Renard option period and bolster working capital.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Dateline Resources faces a US court injunction halting operations at its Colosseum Project, while ASX suspends and then reinstates trading over disclosure timing concerns.

Alterity Therapeutics has won a new US composition of matter patent for its lead drug ATH434, extending intellectual property protection to at least 2045 and boosting its commercial potential ahead of Phase 3 trials in Multiple System Atrophy.

Resouro Strategic Metals has closed its $2.5 million private placement, issuing 10 million shares at 25 cents each to support the environmental program and feasibility study for its Tiros project in Brazil.

Enlitic has launched its cloud-based Ensight platform in the US through a phased deployment with Radiology Imaging Associates, generating an initial annual recurring revenue of approximately US$50,000 and setting the stage for broader expansion.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.